Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 60

1.

The interactome of human EGF/ErbB receptors.

Uetz P, Stagljar I.

Mol Syst Biol. 2006;2:2006.0006. Epub 2006 Jan 31. No abstract available.

2.

Phosphotyrosine interactome of the ErbB-receptor kinase family.

Schulze WX, Deng L, Mann M.

Mol Syst Biol. 2005;1:2005.0008. Epub 2005 May 25.

3.

Actin microfilament aggregation induced by withaferin A is mediated by annexin II.

Falsey RR, Marron MT, Gunaherath GM, Shirahatti N, Mahadevan D, Gunatilaka AA, Whitesell L.

Nat Chem Biol. 2006 Jan;2(1):33-8. Epub 2005 Dec 11.

PMID:
16408090
4.

A systems model of signaling identifies a molecular basis set for cytokine-induced apoptosis.

Janes KA, Albeck JG, Gaudet S, Sorger PK, Lauffenburger DA, Yaffe MB.

Science. 2005 Dec 9;310(5754):1646-53.

5.

Autocrine EGF receptor activation mediates endothelial cell migration and vascular morphogenesis induced by VEGF under interstitial flow.

Semino CE, Kamm RD, Lauffenburger DA.

Exp Cell Res. 2006 Feb 1;312(3):289-98. Epub 2005 Dec 7.

PMID:
16337626
6.

A quantitative protein interaction network for the ErbB receptors using protein microarrays.

Jones RB, Gordus A, Krall JA, MacBeath G.

Nature. 2006 Jan 12;439(7073):168-74. Epub 2005 Nov 6.

PMID:
16273093
7.

Multiple signaling pathways are activated during insulin-like growth factor-I (IGF-I) stimulated breast cancer cell migration.

Zhang X, Lin M, van Golen KL, Yoshioka K, Itoh K, Yee D.

Breast Cancer Res Treat. 2005 Sep;93(2):159-68.

8.

Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody.

Wang Y, Hailey J, Williams D, Wang Y, Lipari P, Malkowski M, Wang X, Xie L, Li G, Saha D, Ling WL, Cannon-Carlson S, Greenberg R, Ramos RA, Shields R, Presta L, Brams P, Bishop WR, Pachter JA.

Mol Cancer Ther. 2005 Aug;4(8):1214-21.

9.

A compendium of signals and responses triggered by prodeath and prosurvival cytokines.

Gaudet S, Janes KA, Albeck JG, Pace EA, Lauffenburger DA, Sorger PK.

Mol Cell Proteomics. 2005 Oct;4(10):1569-90. Epub 2005 Jul 18.

10.

Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules.

Zhang Y, Wolf-Yadlin A, Ross PL, Pappin DJ, Rush J, Lauffenburger DA, White FM.

Mol Cell Proteomics. 2005 Sep;4(9):1240-50. Epub 2005 Jun 11.

12.

ERBB receptors and cancer: the complexity of targeted inhibitors.

Hynes NE, Lane HA.

Nat Rev Cancer. 2005 May;5(5):341-54. Review. Erratum in: Nat Rev Cancer. 2005 Jul;5(7):580.

PMID:
15864276
13.
14.
15.

Cue-signal-response analysis of TNF-induced apoptosis by partial least squares regression of dynamic multivariate data.

Janes KA, Kelly JR, Gaudet S, Albeck JG, Sorger PK, Lauffenburger DA.

J Comput Biol. 2004;11(4):544-61.

PMID:
15579231
16.

Parsing ERK activation reveals quantitatively equivalent contributions from epidermal growth factor receptor and HER2 in human mammary epithelial cells.

Hendriks BS, Orr G, Wells A, Wiley HS, Lauffenburger DA.

J Biol Chem. 2005 Feb 18;280(7):6157-69. Epub 2004 Nov 29.

17.

Src protein-tyrosine kinase structure and regulation.

Roskoski R Jr.

Biochem Biophys Res Commun. 2004 Nov 26;324(4):1155-64. Review.

PMID:
15504335
18.

The interplay between Src and integrins in normal and tumor biology.

Playford MP, Schaller MD.

Oncogene. 2004 Oct 18;23(48):7928-46. Review.

PMID:
15489911
19.

Direct interaction of Cbl with pTyr 1045 of the EGF receptor (EGFR) is required to sort the EGFR to lysosomes for degradation.

Grøvdal LM, Stang E, Sorkin A, Madshus IH.

Exp Cell Res. 2004 Nov 1;300(2):388-95.

PMID:
15475003
20.

Epidermal growth factor receptor inhibition promotes desmosome assembly and strengthens intercellular adhesion in squamous cell carcinoma cells.

Lorch JH, Klessner J, Park JK, Getsios S, Wu YL, Stack MS, Green KJ.

J Biol Chem. 2004 Aug 27;279(35):37191-200. Epub 2004 Jun 16.

Supplemental Content

Support Center